Skip to content

Foghorn Therapeutics Inc.

FHTX· NasdaqCore metricsCIK 1822462

Pharmaceutical preparations553 peers

Last sale
Nov 12, 2026 · -1.44%
Market cap
$123.52M
59.96M shares
Filings
356
$83.54M
Q3 2026+36.8% FY25 yoy
$58.15M
Q3 2026N/M FY25 yoy
$56.64M
Q3 2026N/M FY25 yoy
-$61.41M
Q3 2026derivedN/M FY25 yoy
$0.80
Q3 2026N/M FY25 yoy
$80.30M
Q3 2026+45.8% FY25 yoy
$123.52M
13.1×
1.1×
—
-67.75%
—

Twelve months to Sep 30, 2026 · derived

Price

$2.0653.50%$2.37past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$30.91MFY 2025
$34.16M0FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$30,909,000reported
FY 20242024-12-31$22,602,000reported
FY 20232023-12-31$34,155,000reported
FY 20222022-12-31$19,228,000reported
FY 20212021-12-31$1,319,000reported
FY 20202020-12-31$430,000reported

Pharmaceutical preparations

Foghorn Therapeutics Inc. is the 146th largest of the 554 covered companies the SEC files under this code, by revenue. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Foghorn Therapeutics Inc. · CIK 1822462 · Engraved from SEC EDGAR